Cultural adaptation of the Italian version of the Patient-Reported Outcomes Common Terminology Criteria for Adverse Event (PRO-CTCAE®)

Author:

Caminiti Caterina1ORCID,Bryce Jane2,Riva Silvia3,Ng Diane4,Diodati Francesca1,Iezzi Elisa1,Sparavigna Lucia5,Novello Silvia6,Porta Camillo78ORCID,Del Mastro Lucia9,Procopio Giuseppe10ORCID,Cinieri Saverio11,Falzetta Amalia12,Calabrò Fabio13,Lorusso Vito14,Cogoni Alessio Aligi15,Tortora Giampaolo16,Maruzzo Marco17,Passalacqua Rodolfo18,Cognetti Francesco19,Adamo Vincenzo20,Capelletto Enrica6,Ferrari Alessandra7,Bagnalasta Michela21,Bassi Maurizio21,Nicelli Annalisa21,De Persis Davide22,D’Acunti Alessia23,Iannelli (patient) Elisabetta22,Perrone Francesco5ORCID,Mitchell Sandra A.24

Affiliation:

1. Research and Innovation Unit, University Hospital of Parma, Parma, Italy

2. Ascension St. John Clinical Research Institute, Tulsa, Oklahoma, USA

3. Department of Psychology, St Mary’s University, London, UK

4. Westat Inc, Rockville, Maryland, USA

5. Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Napoli, Italy

6. Department of Oncology, Azienda Ospedaliero-Universitaria San Luigi Gonzaga, Orbassano, Italy

7. Division of Medical Oncology, IRCCS San Matteo University Hospital Foundation, Pavia, Italy

8. Department of Biomedical Sciences and Human Oncology, University of Bari A. Moro, Bari, Italy

9. Department of Medical Oncology, IRCCS Azienda Ospedaliera Universitaria San Martino-IST, Genoa, Italy

10. Fondazione IRCCS, Istituto Nazionale dei Tumori, Oncology Unit 1, Milan, Italy

11. Medical Oncology & Breast Unit, Antonio Perrino Hospital, Brindisi, Italy

12. Ospedale della Val d'Elsa Senese, Poggibonsi, Italy

13. Department of Oncology, San Camillo Forlanini Hospital, Rome, Italy

14. Medical Oncology, Istituto di Ricovero e Cura a Carattere Scientifico Ospedale Oncologico, Bari, Italy

15. Ospedale Civile SS. Annunziata, Sassari, Italy

16. Department of Oncology, G.B. Rossi Hospital, University of Verona, Verona, Italy

17. Oncology Unit 1, Istituto Oncologico Veneto IRCCS, Padova, Italy

18. Division of Medical Oncology, Hospital of Cremona, Cremona, Italy

19. Department of Clinical and Molecular Medicine, Università La Sapienza di Roma, Roma, Italy

20. Medical Oncology Unit, A.O. Papardo & Department of Human Pathology University of Messina, Messina, Italy

21. Fondazione Smith Kline, Verona, Italy

22. Federazione Italiana delle Associazioni di Volontariato in Oncologia - F.A.V.O., Rome, Italy

23. Associazione Italiana Malati di Cancro, parenti ed amici - AIMaC, Rome Italy

24. Division of Cancer Control and Population Sciences, Outcomes Research Branch, National Cancer Institute, Rockville, Maryland, USA

Abstract

Introduction: US National Cancer Institute’s (NCI) Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE®) is a library of 78 symptom terms and 124 items enabling patient reporting of symptomatic adverse events in cancer trials. This multicenter study used mixed methods to develop an Italian language version of this widely accepted measure, and describe the content validity and reliability in a diverse sample of Italian-speaking patients. Methods: All PRO-CTCAE items were translated in accordance with international guidelines. Subsequently, the content validity of the PRO-CTCAE-Italian was explored and iteratively refined through cognitive debriefing interviews. Participants (n=96; 52% male; median age 64 years; 26% older adults; 18% lower educational attainment) completed a PRO-CTCAE survey and participated in a semi-structured interview to determine if the translation captured the concepts of the original English language PRO-CTCAE, and to evaluate comprehension, clarity and ease of judgement. Test-retest reliability of the finalized measure was explored in a second sample (n=135). Results: Four rounds of cognitive debriefing interviews were conducted. The majority of PRO-CTCAE symptom terms, attributes and associated response choices were well-understood, and respondents found the items easy to judge. To improve comprehension and clarity, the symptom terms for nausea and pain were rephrased and retested in subsequent interview rounds. Test-retest reliability was excellent for 41/49 items (84%); the median intraclass correlation coefficient was 0.83 (range 0.64-0.94). Discussion: Results support the semantic, conceptual and pragmatic equivalence of PRO-CTCAE-Italian to the original English version, and provide preliminary descriptive evidence of content validity and reliability.

Funder

Fondazione Smith Kline

Publisher

SAGE Publications

Subject

Cancer Research,Oncology,General Medicine

Reference40 articles.

1. National Cancer Institute, National Institutes of Health. US Department of Health and Human Services: Common Terminology Criteria for Adverse Events (CTCAE), https://evs.nci.nih.gov/ftp1/CTCAE/About.html (accessed 25 January 2022).

2. How Accurate Is Clinician Reporting of Chemotherapy Adverse Effects? A Comparison With Patient-Reported Symptoms From the Quality-of-Life Questionnaire C30

3. The Missing Voice of Patients in Drug-Safety Reporting

4. Patient Online Self-Reporting of Toxicity Symptoms During Chemotherapy

5. Cancer Symptom Assessment Instruments: A Systematic Review

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3